Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

収録刊行物

被引用文献 (23)*注記

もっと見る

問題の指摘

ページトップへ